4 findings
“Compared to 24 m IBC, 12 m IBC was associated with higher odds of axillary lymph node metastases”
Associations
4Extremely dense breast tissue
upin humans1OR 2.05
1 study
Extremely dense breast tissue
upin humans1OR 2.05
Interval breast cancer diagnosed within 1–12 months are associated with extremely dense breast tissue in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 2.05, 95% CI 1.13–3.80).
Humanscompared with interval breast cancer diagnosed at 13–24 monthsbreastfemalesn = 2,122
Triple-negative breast cancer
upin humans1OR 2.08
1 study
Triple-negative breast cancer
upin humans1OR 2.08
Interval breast cancer diagnosed within 1–12 months are associated with triple-negative breast cancer in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 2.08, 95% CI 1.26–3.39).
Humanscompared with interval breast cancer diagnosed at 13–24 monthsbreastfemalesn = 2,122
HER2-positive breast cancer
upin humans1OR 2.1
1 study
HER2-positive breast cancer
upin humans1OR 2.1
Interval breast cancer diagnosed within 1–12 months are associated with HER2-positive breast cancer in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 2.10, 95% CI 1.36–3.22).
Humanscompared with interval breast cancer diagnosed at 13–24 monthsbreastfemalesn = 2,122
Axillary lymph node metastases
upin humans1OR 1.68
1 study
Axillary lymph node metastases
upin humans1OR 1.68
Interval breast cancer diagnosed within 1–12 months are associated with axillary lymph node metastases in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 1.68, 95% CI 1.29–2.19).
Humanscompared with interval breast cancer diagnosed at 13–24 monthsaxillary lymph nodefemalesn = 2,122